Chewy, a leader in pet food, supplies, and healthcare, announced that it has entered into a definitive agreement to acquire SmartPak Equine from Covetrus. The acquisition will expand Chewy’s presence in the equine health category and enhance its portfolio in the high-margin pet wellness sector.
SmartEquine, which rebranded from SmartPak in July 2025, is a leading U.S. provider of equine health products known for its proprietary subscription-based supplement programs and personalized nutrition plans. The company also offers a wide range of tack, gear, and therapeutic products that cater to the specialized needs of horses and riders.
This acquisition strengthens Chewy’s leadership in the equine market and accelerates its entry into higher-margin health and wellness verticals. By combining SmartEquine’s premium product lineup and loyal customer base with Chewy’s logistics infrastructure, technology, and customer service, the company aims to deliver an enhanced experience for equine customers nationwide.
According to Chewy, the transaction is expected to generate several key benefits. It broadens Chewy’s product mix by expanding into the high-margin equine supplements category, enhances recurring revenue through SmartEquine’s subscription model, and increases customer lifetime value among an enthusiastic but underserved customer segment. The acquisition is also expected to be accretive to the adjusted EBITDA margin upon closing.
The deal, structured as an all-cash transaction financed through Chewy’s existing balance sheet, remains subject to customary closing conditions and regulatory approvals. It is anticipated to close in Chewy’s fourth quarter of fiscal year 2025.
KEY QUOTE:
“We are thrilled to welcome SmartEquine to Chewy. Together, we’ll bring even greater expertise, convenience, and care as a trusted destination for the equine community.”
Mita Malhotra, President, Chewy Health
